Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age19+
SponsorNebraska Methodist Health System
About this trial
Randomized trial comparing risk of hospital readmission and hypertensive complications between patients managed on Labetalol compared to Nifedipine.
Eligibility criteria
Qualifiers
None
Disqualifiers
Contraindication to either Nifedipine or Labetalol
HR <60 or >110
Native language other than English or Spanish
Trial design
Treatments tested in this trial
- Labetalol Oral Tablet
- NIFEdipine ER
Treatment groups
600 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov